Trump administration to reconsider some frozen, denied NIH grant submissions

Plus: With Wegovy pill, Novo undercuts Eli Lilly in direct-to-consumer market

December 30, 2025 Check out STAT+

Sponsored By

NIH Trump administration agrees to reconsider frozen and denied NIH grant submissions related to DEI NIH will review grant applications that were frozen, denied, or withdrawn through the agency's standard process of scientific review By Jonathan Wosen and Anil Oza STAT+ | With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market Novo Nordisk pricing decisions suggest it's focusing on patients buying directly, perhaps more so than patients using insurance for weight loss drugs. By Elaine Chen STAT+ | Three major health care policy issues to watch in 2026 ACA premium subsidies, most favored nation drug pricing, and PBM reforms are among health care policy issues to watch in 2026. By John Wilkerson Nick Oxford for STAT STAT's most memorable photos of 2025 Photos of the year 2025: STAT editors unveil their favorite visual moments from the year's top health, science, and medical stories. By Alissa Ambrose and Crystal Milner Opinion: Patients are consulting AI. Doctors should, too Patients are already consulting AI. Med schools and residencies need to catch up. By Angelo Volandes STAT+ | A new drug allowed them to go in the sun for the first time. They're terrified they may have to give it up People with erythropoietic protoporphyria have found reason for hope, but also fret that a treatment that has helped may become inaccessible soon. By Marin Wolf — Boston Globe

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser